Global Wound Biologics Market Size & Outlook, 2022-2030

The wound biologics industry worldwide is expected to reach a projected revenue of US$ 7,490.1 million by 2030. A compound annual growth rate of 8.2% is expected of the worldwide wound biologics industry from 2023 to 2030.
Revenue, 2022 (US$M)
$4,001.9
Forecast, 2030 (US$M)
$7,490.1
CAGR, 2023 - 2030
8.2%
Report Coverage
Worldwide

Global wound biologics market highlights

  • The global wound biologics market generated a revenue of USD 4,001.9 million in 2022 and is expected to reach USD 7,490.1 million by 2030.
  • The market is expected to grow at a CAGR (2023 - 2030) of 8.2% by 2030.
  • In terms of segment, biological skin substitutes accounted for a revenue of USD 1,895.9 million in 2022.
  • Biological Skin Substitutes is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2022.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2023 to 2030.

Global data book summary

Market revenue in 2022USD 4,001.9 million
Market revenue in 2030USD 7,490.1 million
Growth rate8.2% (CAGR from 2022 to 2030)
Largest segmentBiological skin substitutes
Fastest growing segmentBiological Skin Substitutes
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiological Skin Substitutes, Topical Agents, Collagen Dressing Dressing

Other key industry trends

  • In terms of revenue, the North America accounted for 46.7% of the global wound biologics market in 2022.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Kuwait is the fastest growing regional market and is projected to reach USD 13.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Wound Biologics Market Scope

Wound biologics market segmentation & scope
Home Care
Home Care
Home Care
Home Care
Home Care
Physical
Manual Debridement
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Pulse Electrical Field
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Ultrasound Debridement
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Chemical
Ionic Silver
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Iodine
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
EDTA
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Others
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Biological
Dispersin B
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Lactoferrin
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Bacteriophage
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing
Others
End Use
Hospital
Specialty Facilities
Home Care
Research And Manufacturing

Wound Biologics Market Companies

Name Profile # Employees HQ Website

Global wound biologics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wound biologics market will help companies and investors design strategic landscapes.


Biological skin substitutes was the largest segment with a revenue share of 47.37% in 2022. Horizon Databook has segmented the Global wound biologics market based on biological skin substitutes, topical agents, collagen dressing dressing covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Wound Biologics Product Outlook (Revenue, USD Million, 2018-2030)
    • Biological Skin Substitutes
      • Allograft
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Xenograft
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Biosynthetic Products
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
    • Topical Agents
      • End Use
        • Hospital
        • Specialty Facilities
        • Home Care
        • Research And Manufacturing
    • Collagen Dressing Dressing
      • End Use
        • Hospital
        • Specialty Facilities
        • Home Care
        • Research And Manufacturing
    • Physical
      • Manual Debridement
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Pulse Electrical Field
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Ultrasound Debridement
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
    • Chemical
      • Ionic Silver
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Iodine
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • EDTA
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Others
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
    • Biological
      • Dispersin B
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Lactoferrin
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Bacteriophage
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing
      • Others
        • End Use
          • Hospital
          • Specialty Facilities
          • Home Care
          • Research And Manufacturing

Reasons to subscribe to Global wound biologics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global wound biologics market databook

  • Our clientele includes a mix of wound biologics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global wound biologics market , including forecasts for subscribers. This global databook contains high-level insights into Global wound biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global wound biologics market size, by regions, 2018-2030 (US$M)

Top 10 countries: Wound biologics market size, 2022 (US$M)

Global wound biologics market share, by product, 2022 & 2030 (%, US$M)

Wound biologics market: Opportunity assessment by country

Global wound biologics market, by region, 2022 (US$M)

Global wound biologics market size, by regions, 2018-2030 (US$M)

Product 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 1,314.9 1,433.4 1,564.4 1,709.5 1,870.2 2,048.4 2,246.3 2,466.3 2,710.9 2,900.2 3,112.1 3,324.6 3,537.6 8.3%
Europe 693.2 755.0 823.3 898.9 982.6 1,075.4 1,178.3 1,292.6 1,419.7 1,517.6 1,627.2 1,736.9 1,846.8 8.2%
Asia Pacific 442.0 483.1 528.7 579.3 635.5 697.9 767.4 844.7 931.0 998.6 1,074.3 1,150.7 1,227.6 8.6%
Latin America 215.6 232.8 251.5 272.1 294.7 319.5 346.8 376.8 409.9 433.9 460.7 486.9 512.6 7.2%
MEA 163.2 175.3 188.6 203.1 219.0 236.3 255.2 275.9 298.6 314.5 332.1 349.1 365.4 6.6%
Overall 2,828.8 3,079.6 3,356.6 3,662.9 4,001.9 4,377.4 4,793.9 5,256.3 5,770.1 6,164.8 6,606.5 7,048.2 7,490.1 8.2%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more